Cargando…
Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial
OBJECTIVE: To establish the most effective and best tolerated dose of caffeine citrate for the prevention of intermittent hypoxaemia (IH) in late preterm infants. DESIGN: Phase IIB, double-blind, five-arm, parallel, randomised controlled trial. SETTING: Neonatal units and postnatal wards of two tert...
Autores principales: | Oliphant, Elizabeth Anne, McKinlay, Christopher JD, McNamara, David, Cavadino, Alana, Alsweiler, Jane M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985705/ https://www.ncbi.nlm.nih.gov/pubmed/36038256 http://dx.doi.org/10.1136/archdischild-2022-324010 |
Ejemplares similares
-
Caffeine prophylaxis to improve intermittent hypoxaemia in infants born late preterm: a randomised controlled dosage trial (Latte Dosage Trial)
por: Oliphant, Elizabeth Anne, et al.
Publicado: (2020) -
Correction: (Rad 8)Caffeine prophylaxis to improve intermittent hypoxaemia in infants born late preterm: a randomised controlled dosage trial (Latte Dosage Trial)
Publicado: (2020) -
Development and clinical application of a stability-indicating chromatography technique for the quantification of diazoxide
por: Purohit, Trusha J., et al.
Publicado: (2023) -
Continuous glucose monitoring in neonates: a review
por: McKinlay, Christopher J.D., et al.
Publicado: (2017) -
Application of the screening test principles to screening for neonatal hypoglycemia
por: Alsweiler, J. M., et al.
Publicado: (2022)